CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$601M
AUM Growth
-$87.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1
+$28.9M
2
+$16.9M
3
+$15.5M
4
OMER icon
Omeros
OMER
+$10.9M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.97M

Top Sells

1
+$18.9M
2
+$13.9M
3
+$12.7M
4
BPMC
Blueprint Medicines
BPMC
+$11.8M
5
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
+$10.1M

Sector Composition

1 Healthcare 84.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$50.6M 8.38%
900,000
+300,000
2
$37.8M 6.27%
950,000
-475,000
3
$28.9M 4.79%
+21,230
4
$26.1M 4.33%
88,725
+16,250
5
$25.9M 4.29%
1,300,000
+550,000
6
$22.9M 3.8%
300,000
7
$22.4M 3.72%
750,000
+100,000
8
$20.1M 3.33%
270,000
-80,000
9
$19.5M 3.24%
720,000
-80,000
10
$19.1M 3.17%
799,469
-96,157
11
$18.6M 3.09%
367,900
-232,100
12
$17.8M 2.95%
27,172
13
$17.7M 2.93%
1,940,880
14
$17.7M 2.93%
249,677
-38,811
15
$15.8M 2.62%
200,000
16
$15.5M 2.57%
+1,500,000
17
$13.1M 2.17%
1,000,000
-130,000
18
$12.3M 2.04%
159
19
$11.5M 1.91%
250,000
-50,000
20
$10.3M 1.71%
900,000
-198,205
21
$9.97M 1.65%
+125,000
22
$8.9M 1.48%
620,300
23
$8.37M 1.39%
+479,986
24
$7.89M 1.31%
570,000
-630,000
25
$7.53M 1.25%
900,000
1
2 3 4